Rapamycin induces ILT3(high)ILT4(high) dendritic cells promoting a new immunoregulatory pathway.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Kidney International

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ki.2013.337PMID 24107844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients

  2013cited by this paper
• Extrathymically generated regulatory T cells control mucosal TH2 inflammation

  2012cited by this paper
• T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function

  2011cited by this paper
• Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.

  2010cited by this paper
• Human CD34-Derived Myeloid Dendritic Cell Development Requires Intact Phosphatidylinositol 3-Kinase–Protein Kinase B–Mammalian Target of Rapamycin Signaling

  2010cited by this paper
• Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.

  2009cited by this paper
• Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.

  2009cited by this paper
• Monotherapy rapamycin allows an increase of CD4+ CD25bright+ FoxP3+ T cells in renal recipients

  2009cited by this paper
• CD40–CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells

  2009cited by this paper
• Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathway

  2008cited by this paper
• Regulatory T cells and T cell depletion: role of immunosuppressive drugs.

  2007cited by this paper
• Targeting mammalian target of rapamycin (mTOR) for health and diseases.

  2007cited by this paper
• Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1

  2007cited by this paper
• Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’)

  2007cited by this paper
• Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

  2006cited by this paper
• Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells1

  2006cited by this paper
• Tolerization of dendritic cells by HLA‐G

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Regulatory T cells in transplantation tolerance.

  2005cited by this paper
• Regulatory T-cell therapy: is it ready for the clinic?

  2005cited by this paper
• A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3

  2005cited by this paper
• Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.

  2005cited by this paper
• Regulatory T Cells in Immunologic Self-Tolerance and Autoimmune Disease

  2005cited by this paper
• Interleukin 10 regulates cell surface and soluble LIR‐2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro

  2004cited by this paper
• Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery1

  2004cited by this paper
• Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.

  2004cited by this paper
• The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade.

  2003cited by this paper
• High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells.

  2003cited by this paper
• Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance1

  2002cited by this paper
• Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4

  2002cited by this paper
• Immune inhibitory receptors.

  2000cited by this paper
• The antigen dose determines T helper subset development by regulation of CD40 ligand

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells.

  2000cited by this paper
• Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells.

  1999cited by this paper
• Th1 and Th2 cytokines in organ transplantation: paradigm lost?

  1999cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells.

  1998cited by this paper
• Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.

  1998cited by this paper
• A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing

  1997cited by this paper
• Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.

  1995cited by this paper

• From Senescent Cells to Systemic Inflammation: The Role of Inflammaging in Age-Related Diseases and Kidney Dysfunction

  2025cites this paper
• Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients at high risk of delayed graft function.

  2025cites this paper
• Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications

  2025cites this paper
• A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway

  2025cites this paper
• Dendritic Cells: Origin, Classification, Development, Biological Functions, and Therapeutic Potential

  2025cites this paper
• Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment

  2024cites this paper
• Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting

  2024cites this paper
• Emerging strategies for treating autoimmune disease with genetically modified dendritic cells

  2024cites this paper
• Everolimus treatment enhances inhibitory immune checkpoint molecules' expression in monocyte-derived dendritic cells.

  2024cites this paper
• LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets

  2024cites this paper
• Leukocyte immunoglobulin‐like receptor B4: A keystone in immune modulation and therapeutic target in cancer and beyond

  2024cites this paper
• Inhibitory innate receptors and their potential role in transplantation.

  2023cites this paper
• Molecular regulatory mechanism of LILRB4 in the immune response

  2023cites this paper
• Human leukocyte immunoglobulin-like receptors in health and disease

  2023cites this paper
• Myeloid checkpoints for cancer immunotherapy.

  2022cites this paper
• The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity

  2022cites this paper
• mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction

  2021cites this paper
• Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies

  2021cites this paper
• Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials

  2021cites this paper
• Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer

  2021cites this paper
• Dendritic Cells: Versatile Players in Renal Transplantation

  2021cites this paper
• Low C3 Serum Levels Predict Severe Forms of STEC-HUS With Neurologic Involvement

  2020cites this paper
• Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients

  2020cites this paper
• Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses

  2020cites this paper
• Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation

  2020cites this paper
• Analysis of the Application of Regulatory Dendritic Cells in Kidney Transplantation

  2020cites this paper
• Expression of HLA-G and its receptors in relation to transplant acceptance

  2020cites this paper
• Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus

  2019cites this paper
• Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand?

  2019cites this paper
• mTOR and Aging: An Old Fashioned Dress

  2019cites this paper
• Frequency of dendritic cell subsets and ILT3, ILT4 gene expression in two different immunosuppressive protocols in kidney transplant recipients. A cohort report

  2019cites this paper
• The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review

  2018cites this paper
• Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice

  2018influential citation
• ILT4 functions as a potential checkpoint molecule for tumor immunotherapy.

  2018cites this paper
• Advances on CD8+ Treg Cells and Their Potential in Transplantation.

  2018cites this paper
• mTOR Inhibition Role in Cellular Mechanisms

  2018cites this paper
• Human CD8+CD28− T Suppressor Cells Expanded by IL-15 In Vitro Suppress in an Allospecific and Programmed Cell Death Protein 1-Dependent Manner

  2018cites this paper
• The impact of metabolic reprogramming on dendritic cell function

  2018cites this paper
• Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin

  2018cites this paper
• Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression.

  2018cites this paper
• Las células T reguladoras FoxP3 como biomarcador predictivo de la función del injerto renal: Revisión sistemática multietapa

  2018influential citation
• Recuentos de células T reguladoras en sangre periférica como biomarcador predictivo del resultado del trasplante renal: revisión sistemática

  2017cites this paper
• Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity

  2017cites this paper
• Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review.

  2017cites this paper
• mTOR inhibitors effects on regulatory T cells and on dendritic cells

  2016cites this paper
• Association of Human Leukocyte Antigen-G Polymorphisms and Clinical Outcomes Post-Transplantation

  2016cites this paper
• Immunological characteristics of renal transplant tolerance in humans.

  2016influential citation
• An mTOR‐inhibitor‐based protocol and calcineurin inhibitor (CNI)‐free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI

  2016cites this paper
• Leukocyte Ig-Like Receptors – A Model for MHC Class I Disease Associations

  2016cites this paper
• Molecular and Cellular Characterization of Human CD8 T Suppressor Cells

  2016cites this paper
• Dendritic Cells and Macrophages: Sentinels in the Kidney.

  2015cites this paper
• Dendritic Cells and Macrophages: Sentinels in the

  2015cites this paper
• Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man

  2015cites this paper
• The diverging roles of dendritic cells in kidney allotransplantation.

  2015cites this paper
• Evolving Perspectives of mTOR Complexes in Immunity and Transplantation

  2015cites this paper
• HLA-G: An Immune Checkpoint Molecule.

  2015cites this paper
• Targeting Dendritic Cell Function during Systemic Autoimmunity to Restore Tolerance

  2014cites this paper
• HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy

  2014cites this paper
• A window into immunosuppressant immunoregulation: recipient conversion to rapamycin increases potentially tolerogenic immune cells.

  2014cites this paper